Prevalence of organ symptoms in allo-HCT survivors and their impact on work and daily life

  • Matsuura Tomoko
    Nursing Division, National Cancer Center Hospital, Tokyo, Japan Nursing Division, National Hospital Organization Kyusyu Cancer Center, Fukuoka, Japan
  • Kurosawa Saiko
    Department of oncology, Ina Central Hospital Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital
  • Yamaguchi Takuhiro
    Division of Biostatistics, Tohoku University Graduate School of Medicine, Sendai, Japan
  • Mori Ayako
    Nursing Division, National Cancer Center Hospital, Tokyo, Japan
  • Mori Takehiko
    Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan Department of Hematology, Tokyo Medical and Dental University, Tokyo, Japan
  • Tanaka Masatsugu
    Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan
  • Kondo Tadakazu
    Department of Hematology, Kyoto University Hospital, Kyoto, Japan
  • Sakamoto Shuko
    Department of Hematology, Aomori Prefectural Central Hospital, Aomori, Japan
  • Fujii Nobuharu
    Division of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
  • Ichinohe Tatsuo
    Department of Hematology, Hiroshima University Hospital, Hiroshima, Japan
  • Nara Miho
    Division of Hematology, Akita University Hospital, Akita, Japan
  • Maeda Tomoya
    Department of Hemato-Oncology, Saitama Medical University International Medical Center, Saitama, Japan
  • Fujisawa Shin
    Department of Hematology, Yokohama City University Medical Center, Yokohama, Japan
  • Nawa Yuichiro
    Division of Hematology, Cancer Center, Ehime Prefectural Central Hospital, Matsuyama, Japan
  • Nakamura Yukinori
    Third Department of Internal Medicine, Yamaguchi University School of Medicine, Yamaguchi, Japan
  • Minamiguchi Hitoshi
    Division of Hematology, Shiga University of Medical Science, Otsu, Japan
  • Onishi Yasushi
    Department of Hematology, Tohoku University Hospital, Sendai, Japan
  • Takano Kuniko
    Department of Hematology, Oita University Hospital, Oita, Japan
  • Takahashi Miyako
    Japan Cancer Survivorship Network, Tokyo, Japan
  • Fukuda Takahiro
    Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital

Bibliographic Information

Other Title
  • 同種移植後患者の就労に関する実態調査―慢性GVHD等の自覚症状による仕事・生活への影響に関する検討―

Search this article

Abstract

<p> We conducted a nationwide cross-sectional questionnaire study to assess the prevalence of organ symptoms in allogeneic hematopoietic cell transplantation (allo-HCT) survivors and its impact on work and daily life. We targeted allo-HCT survivors employed at diagnosis, aged 20-64 at survey, and who survived≥2 years without relapse. The questionnaire included the presence or absence of 34 organ symptoms and their impact on work and daily life, as well as patient-, HCT-, and work-related factors. A total of 841 participants who were working at the time of the survey were included in the analysis (response rate, 60%). Ninety-two percent of participants had at least one symptom; the skin (78%), joints/muscles (72%), eyes (61%), and psychological health (44%) were frequently affected. Multivariable logistic regression analysis of the impact of symptoms on work showed that different job types were independently associated with different symptoms: indoor/physical work (medical care staff, etc.) with itching, dry eyes, restricted joint mobility; outdoor/light duty (sales staff, etc.) with thinning of hair and depressive state; and outdoor/physical work (construction, etc.) with dazzling. Our findings indicated that it may be effective to provide individual intervention and education that take into consideration both survivors’ symptoms and their work/life conditions.</p>

Journal

References(16)*help

See more

Details 詳細情報について

Report a problem

Back to top